1. The Role of ERα36 in Development and Tumor Malignancy
   Charlène Thiebaut et al, 2020, International Journal of Molecular Sciences CrossRef
2. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior
   Yu-Jie Dai et al, 2018, Cellular Oncology CrossRef
3. Estrogen receptors in gastric cancer: Advances and perspectives
   Muhammad Saif Ur Rahman, 2016, World Journal of Gastroenterology CrossRef
4. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
   Ji Woong Kim et al, 2021, Cells CrossRef
5. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs
   Zhen Zeng et al, 2021, Cells CrossRef
6. GRP78 positively regulates estrogen-stimulated cell growth mediated by ER-α36 in gastric cancer cells
   Zhengqi Fu et al, 2017, Molecular Medicine Reports CrossRef
7. Knockdown of ER‐α36 expression inhibits glioma proliferation, invasion and epithelial‐to‐mesenchymal transition
   Bowen Zhao et al, 2022, The Anatomical Record CrossRef
8. Distribution of FSHR and ER-α and Their Colocalization with GnRHR in Gastric Carcinoma
   玉涛 马, 2018, Asian Case Reports in Oncology CrossRef
9. Estrogen receptor variant ER-α36 is involved in estrogen neuroprotection against oxidative toxicity
   S. Han et al, 2015, Neuroscience CrossRef
10. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma
    Chien-Yu Huang et al, 2016, Tumor Biology CrossRef
11. ERα36 – Another piece of the estrogen puzzle
    Kamil Sołtysik et al, 2015, European Journal of Cell Biology CrossRef
12. Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells
    Elisa Tramentozzi et al, 2016, Oncotarget CrossRef